Nick BirdNick Bird first became involved in the charity in 2009 when his youngest son, Adam, was diagnosed with high-risk neuroblastoma.

After Adam showed little response to standa
rd frontline therapy, Nick and his family travelled with him to both Germany and America for treatment. While seeking options for Adam, Nick became more involved in research, attending symposiums and meetings.

Following Adam’s death in 2013, Nick continued to engage in activities relating to research and advocacy on behalf of o
ther children with neuroblastoma. In 2016 he became a member of the National Cancer Research Institute Children’s Cancer & Leukaemia Clinical Studies Group (NCRI CCL CSG), as well as a member of the specialist sub-group for neuroblastoma.

Nick joined Solving Kids' Cancer's Board of Trustees in April 2016 and became Chair in November 2018. He is committed to trying to improve the outlook for children in the UK diagnosed neuroblastoma.

Outside of his voluntary life he works for a technology company in the financial services sector and lives in Epsom with his wife and their two other children. In his spare time, he enjoys swimming, cycling, and running, and has completed a number of marathons … with several more to come (he says!).

"Neuroblastoma claims the lives of infants and young children, just starting out in life. Whilst there are brilliant doctors and researchers trying to find new ways to beat this disease, at present the most effective weapons continue to be the old artillery of chemotherapy, radiotherapy and surgery. And despite the most intensive treatment regime for any cancer, over half the children diagnosed with high-risk neuroblastoma still go on to die, whilst the majority of those who survive are left with serious, life-long, side-effects.

Researchers need our help; to engage with them, challenge them, steer them, support them, push them, and provide the funding commitments that make research happen, that in turn makes change happen. We must speak up for the children affected by this terrible disease, for they are simply too young to have a voice of their own."